Health
Osteoporosis drugs linked to reduced risk of Alzheimer's disease
Fox News reports that a study of Hong Kong adults linked certain osteoporosis medications to lower dementia risk.
The short version
- A study of 121,492 adults aged 60 or older found nitrogen-containing bisphosphonate (NBP) use associated with a 16% lower risk of Alzheimer's disease and related dementias compared to non-users.[Fox News]
- NBP users also showed a 24% lower risk of dementia when compared to individuals taking non-NBP osteoporosis drugs.[Fox News]
- Researchers emphasized that the observational study does not prove cause and effect, requiring verification through randomized clinical trials.[Fox News]
Key facts
- A study of 121,492 adults aged 60 and older linked nitrogen-containing bisphosphonates to a 16% lower risk of Alzheimer's and related dementias compared to taking no osteoporosis drugs.[Fox News]
- NBP usage was associated with a 24% lower dementia risk compared to non-NBP osteoporosis treatments.[Fox News]
- Common NBPs evaluated include alendronate, ibandronate, risedronate, and zoledronate.[Fox News]
- The research was published in the journal Alzheimer's & Dementia.[Fox News]
What remains uncertain
- The study was purely observational and cannot demonstrate direct causation without a randomized clinical trial.[Fox News]
- It is unknown if the findings generalize beyond the Chinese population studied.[Fox News]
- The study lacked baseline cognitive testing and could not account for unmeasured factors like education level, social isolation, air pollution, and vision loss.[Fox News]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.